Convalescent Plasma for the Treatment of Severe COVID-19

Convalescent Plasma for the Treatment of Severe COVID-19

Massimo Franchini, Giancarlo Maria Liumbruno Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, ItalyCorrespondence: Massimo FranchiniDepartment of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantova, ItalyTel +039-0376-201234Fax +039-0376-220144Email mass...

Full description

Bibliographic Details
Main Authors:	Franchini M, Liumbruno GM
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	Biologics: Targets & Therapy
Subjects:	sars-cov-2 covid-19 hyperimmune plasma convalescent plasma therapy
Online Access:	https://www.dovepress.com/convalescent-plasma-for-the-treatment-of-severe-covid-19-peer-reviewed-article-BTT

Similar Items

The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01)

Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
by: Massimo Franchini, et al.
Published: (2021-06-01)

Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
by: Massimo Franchini, et al.
Published: (2024-02-01)

Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience
by: Maria Grazia Cusi, et al.
Published: (2021-07-01)

Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
by: Katerina Jazbec, et al.
Published: (2023-03-01)

Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial
by: Joan Bargay-Lleonart, et al.
Published: (2022-05-01)

Plasma convalescent therapy for COVID-19 patients: A literature review.
by: Tania Platero-Portillo, et al.
Published: (2020-09-01)

Facts and challenges in convalescent plasma therapy in COVID-19
by: Kumar H
Published: (2020-12-01)

In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
by: Gabriel Rojas-Jiménez, et al.
Published: (2022-01-01)

Convalescent Plasma a Potential Therapy in Covid-19 Patients in Low Resource Setting
by: Abdelrahman H. Abdelmoneim, et al.
Published: (2020-04-01)

COVID-19: benefits and risks of passive immunotherapeutics
by: Ankur Gupta, et al.
Published: (2020-12-01)

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
by: Douglas Tremblay, et al.
Published: (2020-11-01)

Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial
by: Rada M. Grubovic Rastvorceva, et al.
Published: (2022-10-01)

Utility of convalescent plasma for COVID-19 treatment
by: Prasanta Kumar Ghosh
Published: (2020-01-01)

Convalescent plasma: A potential therapeutic option for COVID-19 patients
by: Swee Li Ng, et al.
Published: (2020-01-01)

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
by: David Sullivan, et al.
Published: (2023-06-01)

Convalescent (Immune) Plasma Therapy with all Aspects: Yesterday, Today and COVID-19
by: Öner Özdemir, et al.
Published: (2020-06-01)

Convalescent Plasma in the Treatment of Severe COVID-19: A Systematic Review and Meta-Analysis
by: Xuanguo ZHANG, et al.
Published: (2020-10-01)

Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022-01-01)

Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
by: Jaffar A. Al-Tawfiq, et al.
Published: (2020-12-01)

Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme—The South African Experience
by: Tanya Nadia Glatt, et al.
Published: (2021-10-01)

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
by: Tengfei Ma, et al.
Published: (2022-01-01)

Convalescent plasma therapy - a silver lining for COVID-19 management?
by: Sumit Saha, et al.
Published: (2021-04-01)

The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review
by: Massimo Franchini, et al.
Published: (2023-12-01)

Convalescent Plasma Therapy for COVID-19: Current Status and Future Directions
by: Jayanth Seshan, et al.
Published: (2020-09-01)

Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)
by: Alice T.W. Song, et al.
Published: (2022-06-01)

Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan
by: Tehmina Nafees Sonia Khan, et al.
Published: (2021-09-01)

Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
by: Parastoo Hosseini, et al.
Published: (2021-03-01)

Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study
by: Adam Tworek, et al.
Published: (2021-04-01)

Convalescent Plasma: An Old Trick for the Treatment of COVID-19
by: Reza Jafari, et al.
Published: (2020-07-01)

Convalescent plasma therapy in COVID-19
by: Ayse Uysal, et al.
Published: (2022-06-01)

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis
by: Vasiliki Pappa, et al.
Published: (2021-04-01)

Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease progression
by: Ingvild Birschmann, et al.
Published: (2022-09-01)

Use of convalescent plasma to treat COVID-19: case studies
by: Stéphani Caroline Beneti, et al.
Published: (2023-07-01)

Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives – current situation and perspectives
by: Adriana Tamburello, et al.
Published: (2020-04-01)

A Collaborative Effort to Establish a Convalescent Plasma Program in South Florida
by: Roberto L. Roman Laporte, et al.
Published: (2020-12-01)

Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study
by: Manuel Rojas, et al.
Published: (2022-06-01)

Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
by: Massimo Franchini, et al.
Published: (2024-02-01)

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
by: Karin Holm, et al.
Published: (2021-12-01)

Why will it never be known if convalescent plasma is effective for COVID-19
by: Manuel Rojas, et al.
Published: (2020-01-01)